Jun‐Li Luo

7.0k total citations · 4 hit papers
47 papers, 5.5k citations indexed

About

Jun‐Li Luo is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jun‐Li Luo has authored 47 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Cancer Research and 16 papers in Immunology. Recurrent topics in Jun‐Li Luo's work include NF-κB Signaling Pathways (12 papers), Immune Response and Inflammation (7 papers) and interferon and immune responses (4 papers). Jun‐Li Luo is often cited by papers focused on NF-κB Signaling Pathways (12 papers), Immune Response and Inflammation (7 papers) and interferon and immune responses (4 papers). Jun‐Li Luo collaborates with scholars based in China, United States and Germany. Jun‐Li Luo's co-authors include Michael Karin, Shin Maeda, Hyam L. Leffert, Hideaki Kamata, Sergei I. Grivennikov, Li‐Chung Hsu, Hiroyuki Takahashi, Pascal Descargues, Wan‐Wan Lin and Sun-Hwa Kim and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Jun‐Li Luo

42 papers receiving 5.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis

2005 948 citations Shin Maeda, Hideaki Kamata et al. Cell profile →
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

2008 885 citations Jun‐Li Luo, Michael Karin et al. Nature profile →
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy

2005 712 citations Jun‐Li Luo profile →
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

2010 481 citations Jun‐Li Luo, Michael Karin et al. Nature profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jun‐Li Luo	2.7k	2.2k	1.9k	1.9k	530	47	5.5k
Francesca Zazzeroni	3.0k 1.1×	1.2k 0.6×	1.6k 0.8×	1.0k 0.6×	566 1.1×	96	5.3k
Shabnam Shalapour	2.8k 1.0×	2.0k 0.9×	975 0.5×	1.7k 0.9×	1.1k 2.0×	40	6.0k
Jung-Mao Hsu	3.5k 1.3×	1.6k 0.7×	1.0k 0.5×	3.0k 1.6×	322 0.6×	56	6.1k
Ilan Stein	2.6k 1.0×	956 0.4×	1.6k 0.9×	968 0.5×	406 0.8×	31	4.5k
Pengyuan Yang	3.4k 1.3×	1.0k 0.5×	1.7k 0.9×	816 0.4×	525 1.0×	113	5.4k
Hasan Körkaya	3.7k 1.4×	1.1k 0.5×	1.9k 1.0×	4.1k 2.2×	231 0.4×	63	7.1k
Yukihiro Nishio	2.7k 1.0×	1.9k 0.9×	1.2k 0.6×	1.9k 1.0×	584 1.1×	60	6.3k
Zhong Chen	2.4k 0.9×	812 0.4×	1.5k 0.8×	1.7k 0.9×	265 0.5×	74	4.2k
Julianna Blagih	3.2k 1.2×	3.2k 1.5×	2.0k 1.0×	1.4k 0.7×	731 1.4×	29	6.8k
Alexandru Almasan	4.4k 1.6×	951 0.4×	1.0k 0.5×	1.9k 1.0×	671 1.3×	96	6.5k

Countries citing papers authored by Jun‐Li Luo

Since Specialization

Citations

This map shows the geographic impact of Jun‐Li Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Li Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Li Luo more than expected).

Fields of papers citing papers by Jun‐Li Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun‐Li Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Li Luo. The network helps show where Jun‐Li Luo may publish in the future.

Co-authorship network of co-authors of Jun‐Li Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jun‐Li Luo. A scholar is included among the top collaborators of Jun‐Li Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun‐Li Luo. Jun‐Li Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Maoyong, et al.. (2025). Potassium isotope constraints on brine sources and evolution in Qaidam Basin, Tibetan Plateau. Ore Geology Reviews. 181. 106632–106632. 1 indexed citations

Huang, Liping, Jun‐Li Luo, Yifan Wang, et al.. (2025). Risk factor of postoperative pulmonary complications after colorectal cancer surgery: an analysis of nationwide inpatient sample. Scientific Reports. 15(1). 2717–2717. 2 indexed citations

Chang, Yujie, et al.. (2025). Combining gut microbiota modulation and immunotherapy: A promising approach for treating microsatellite stable colorectal cancer. Critical Reviews in Oncology/Hematology. 208. 104629–104629. 4 indexed citations

Wen, Jingyi, et al.. (2025). The role of GPI-anchored LY6/uPAR family proteins in connecting membrane microdomains with immune regulation and diseases. Critical Reviews in Oncology/Hematology. 216. 104971–104971.

Li, Xi, et al.. (2025). The functions of FXYD family members in human health and disease. Genes & Diseases. 13(3). 101847–101847.

Liu, Qingqing, et al.. (2024). Triple-Negative Breast Cancer Intrinsic FTSJ1 Favors Tumor Progression and Attenuates CD8+ T Cell Infiltration. Cancers. 16(3). 597–597. 3 indexed citations

Chen, Xueyan, Weilin Wu, Ji-Hak Jeong, et al.. (2024). Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance. Science China Life Sciences. 67(7). 1413–1426. 3 indexed citations

Liu, Qingqing, Min Long, Xueyan Chen, et al.. (2023). DDX5 Functions as a Tumor Suppressor in Tongue Cancer. Cancers. 15(24). 5882–5882. 3 indexed citations

Jeong, Ji-Hak, Shangwei Zhong, Fuzhuo Li, et al.. (2022). Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of Experimental Medicine. 220(3). 17 indexed citations

10.

Zhao, Lan, Jun‐Li Luo, Md Khadem Ali, Edda Spiekerkoetter, & Mark R. Nicolls. (2022). The Human Respiratory Microbiome: Current Understandings and Future Directions. American Journal of Respiratory Cell and Molecular Biology. 68(3). 245–255. 37 indexed citations

11.

Zhao, Lan, William C. Cho, & Jun‐Li Luo. (2022). Exploring the patient-microbiome interaction patterns for pan-cancer. Computational and Structural Biotechnology Journal. 20. 3068–3079. 5 indexed citations

12.

Huang, Changhao, Shangwei Zhong, HaJeung Park, Ji-Hak Jeong, & Jun‐Li Luo. (2020). A Simple and Efficient System for Producing Recombinant Human CXCL8 in Escherichia coli. Journal of Interferon & Cytokine Research. 40(9). 460–465. 2 indexed citations

13.

Chen, Wen, Zijian Zhang, Yuxiang He, et al.. (2017). Intensity-modulated radiotherapy, volume-modulated arc therapy and helical tomotherapy for locally advanced nasopharyngeal carcinoma: a dosimetric comparison. Translational Cancer Research. 6(5). 929–939. 2 indexed citations

14.

Nuruzzaman, Mohammed, Hongzhe Cao, Tiao Luo, et al.. (2016). Transcriptomics-based identification of <italic>WRKY</italic> genes and characterization of a salt and hormone-responsive <italic>PgWRKY1</italic> gene in <italic>Panax ginseng</italic>. Acta Biochimica et Biophysica Sinica. 48(2). 117–131. 30 indexed citations

15.

Matsuzawa, Atsushi, Ping‐Hui Tseng, Sivakumar Vallabhapurapu, et al.. (2008). Essential Cytoplasmic Translocation of a Cytokine Receptor–Assembled Signaling Complex. Science. 321(5889). 663–668. 179 indexed citations

16.

Luo, Jun‐Li, Wei Phin Tan, Jill M. Ricono, et al.. (2007). Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin. Nature. 446(7136). 690–694. 337 indexed citations

17.

Maeda, Shin, Hideaki Kamata, Jun‐Li Luo, Hyam L. Leffert, & Michael Karin. (2005). IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis. Cell. 121(7). 977–990. 948 indexed citations breakdown →

18.

Hsu, Li‐Chung, Jin Mo Park, Kezhong Zhang, et al.. (2004). The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature. 428(6980). 341–345. 313 indexed citations

19.

Luo, Jun‐Li, Shin Maeda, Li‐Chung Hsu, Hideo Yagita∥, & Michael Karin. (2004). Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell. 6(3). 297–305. 499 indexed citations

20.

Maeda, Shin, Lufen Chang, Zhiwei Li, et al.. (2003). IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα. Immunity. 19(5). 725–737. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact